Key Financial Data Of Reporting Company

Fuji Pharma Co.,Ltd. - Filing #7364276

Concept As at
2023-09-30
2022-10-01 to
2023-09-30
As at
2023-09-30
2022-10-01 to
2023-09-30
2021-10-01 to
2022-09-30
As at
2022-09-30
As at
2022-09-30
2021-10-01 to
2022-09-30
As at
2021-09-30
2020-10-01 to
2021-09-30
As at
2021-09-30
2020-10-01 to
2021-09-30
2019-10-01 to
2020-09-30
As at
2020-09-30
As at
2020-09-30
2019-10-01 to
2020-09-30
2018-10-01 to
2019-09-30
As at
2019-09-30
2018-10-01 to
2019-09-30
As at
2019-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
37,421,000,000 JPY
40,889,000,000 JPY
32,554,000,000 JPY
35,426,000,000 JPY
31,859,000,000 JPY
33,990,000,000 JPY
31,260,000,000 JPY
33,793,000,000 JPY
33,740,000,000 JPY
36,279,000,000 JPY
Ordinary profit (loss)
4,071,000,000 JPY
4,519,000,000 JPY
3,395,000,000 JPY
3,725,000,000 JPY
3,319,000,000 JPY
3,250,000,000 JPY
2,807,000,000 JPY
2,983,000,000 JPY
3,966,000,000 JPY
4,169,000,000 JPY
Profit (loss)
3,117,000,000 JPY
2,480,000,000 JPY
2,554,000,000 JPY
2,015,000,000 JPY
2,842,000,000 JPY
Share capital
3,799,000,000 JPY
3,799,000,000 JPY
3,799,000,000 JPY
3,799,000,000 JPY
3,799,000,000 JPY
Total number of issued shares
24,753,800 xbrli:shares
24,753,800 xbrli:shares
24,753,800 xbrli:shares
31,253,800 xbrli:shares
31,253,800 xbrli:shares
Net assets
38,977,000,000 JPY
41,177,000,000 JPY
34,508,000,000 JPY
35,806,000,000 JPY
32,595,000,000 JPY
32,681,000,000 JPY
39,596,000,000 JPY
39,961,000,000 JPY
39,363,000,000 JPY
38,785,000,000 JPY
Total assets
79,995,000,000 JPY
85,332,000,000 JPY
71,263,000,000 JPY
75,538,000,000 JPY
62,085,000,000 JPY
64,239,000,000 JPY
59,288,000,000 JPY
61,962,000,000 JPY
60,737,000,000 JPY
57,350,000,000 JPY
Net assets per share
1,603.83
1,694.23
1,420.42
1,473.73
1,342.10
1,345.56
1,270.79
1,282.43
1,263.51
1,245.03
Dividend paid per share
37.00
35.00
29.00
29.00
29.00
Interim dividend paid per share
17.00
15.00
14.00
14.00
14.00
Basic earnings (loss) per share
128.27
141.37
102.10
111.01
95.10
90.54
64.70
66.94
93.10
97.04
Diluted earnings per share
Equity-to-asset ratio
0.487 xbrli:pure
0.483 xbrli:pure
0.484 xbrli:pure
0.474 xbrli:pure
0.525 xbrli:pure
0.509 xbrli:pure
0.668 xbrli:pure
0.645 xbrli:pure
0.648 xbrli:pure
0.676 xbrli:pure
Rate of return on equity
0.085 xbrli:pure
0.089 xbrli:pure
0.074 xbrli:pure
0.079 xbrli:pure
0.071 xbrli:pure
0.067 xbrli:pure
0.051 xbrli:pure
0.053 xbrli:pure
0.077 xbrli:pure
0.079 xbrli:pure
Price-earnings ratio
9.09 xbrli:pure
8.25 xbrli:pure
10.13 xbrli:pure
9.31 xbrli:pure
12.30 xbrli:pure
12.92 xbrli:pure
19.31 xbrli:pure
18.66 xbrli:pure
14.15 xbrli:pure
13.57 xbrli:pure
Payout ratio
0.288 xbrli:pure
0.343 xbrli:pure
0.305 xbrli:pure
0.448 xbrli:pure
0.312 xbrli:pure
Net cash provided by (used in) operating activities
1,917,000,000 JPY
-658,000,000 JPY
5,993,000,000 JPY
5,770,000,000 JPY
7,035,000,000 JPY
Net cash provided by (used in) investing activities
-5,240,000,000 JPY
-11,271,000,000 JPY
-2,345,000,000 JPY
-2,616,000,000 JPY
-12,024,000,000 JPY
Net cash provided by (used in) financing activities
1,915,000,000 JPY
5,094,000,000 JPY
-5,435,000,000 JPY
450,000,000 JPY
7,265,000,000 JPY
Cash and cash equivalents
2,324,000,000 JPY
3,546,000,000 JPY
10,199,000,000 JPY
12,041,000,000 JPY
8,494,000,000 JPY
Number of employees
866 xbrli:pure
1,621 xbrli:pure
817 xbrli:pure
1,560 xbrli:pure
791 xbrli:pure
1,532 xbrli:pure
779 xbrli:pure
1,550 xbrli:pure
1,527 xbrli:pure
761 xbrli:pure
Average number of temporary employees
91 xbrli:pure
Total shareholder return
0.739 xbrli:pure
0.613 xbrli:pure
0.666 xbrli:pure
0.692 xbrli:pure
0.712 xbrli:pure
Total return on share price index
1.445 xbrli:pure
1.234 xbrli:pure
1.329 xbrli:pure
1.042 xbrli:pure
0.993 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.